The WHO recently produced updated guidelines for managers of helminth control programmes, specifically targeting soil-transmitted helminthiasis (STH) and schistosomiasis in school-age children [1] . In the case of schistosomiasis, this strategic document advocates treatment with praziquantel (PZQ) as the cornerstone of control, with the objective of reducing infection-associated morbidity, which is estimated to be 70 million disabilityadjusted life years (DALYs). There are, however, other helminth infections currently absent from these guidelines that can result in important morbidity effects in children and are also treatable with PZQ. An important example is hymenolepiasis, which is caused by a cyclophyllidean tapeworm from the genus Hymenolepis.
Hymenolepiasis was first recognised in the small intestine of a boy in Cairo in 1851 by Bilharz [2] . The two species of Hymenolepis infecting man, namely H. nana and H. diminuta, are ubiquitous and H. nana is by far the most common of the two parasites. H. nana infections are considered to be the most prevalent human cestodiasis in the world [2] [3] [4] . Studies over the past 50 years documenting the prevalence of H. nana indicate that in some communities this infection can reach prevalence as high as 21% in children (see Text S1). Cases of hymenolepiasis are often seen as clusters within a family and in institutions where children are crowded together (e.g., orphanages, childcare centres, and boarding schools) [2, [5] [6] [7] , suggesting a common source of exposure. The majority of infections occur as autoinfections as a result of contamination of food or water by humans, usually children, excreting viable eggs in their faeces [4] . While most H. nana infections are usually asymptomatic, numerous studies have documented that heavy infections with H. nana can cause severe morbidity in children, including severe diarrhoea, abdominal pain, decreased appetite, irritable behaviour, anal or nasal pruritus, and reduced growth [2, 4, [7] [8] [9] .
Similarly to schistosomiasis, a single dose of PZQ eliminates the vast majority of Hymenolepis egg excretion [10] [11] [12] . However, it is likely that a PZQ gap exists in many communities being targeted by MDA in that the geographical location of Hymenolepis infections may not necessarily overlap with that of schistosomiasis. Guiding PZQ delivery solely on the basis of the distribution of schistosomiasis may miss communities endemic to Hymenolepis infection also in need of PZQ. This means that the populations at risk of hymenolepiasis may need to also be identified so that PZQ delivery can be extended to those areas.
In order to test our proposition, we have analysed data from a parasitic disease survey of 2,168 children aged #15 years, including 1,098 girls and 1,070 boys in the Dande municipality in Northern Angola. Previous analysis of this dataset revealed that children were at significantly increased risk of H. nana infection (prevalence of 6.2% [95% CI: 4.9-7.8%] in preschool children and 7.3% [95% CI: 5.8-9.0%] in school-age children) compared to adults (prevalence of 1.9% [95% CI: 1.1-3.1%]) [13] . Using these data, we aimed to describe the epidemiology of H. nana infection by quantifying the role of individual and household factors and the physical environment (land surface temperature, distance to irrigation canals and rivers) in H. nana infection; quantify the role of H. nana infection on morbidity outcomes such as anaemia, diarrhoea, abdominal pain, and growth; quantify the geographical variation in H. nana infection prevalence in children aged #15 years; generate the first high-resolution H. nana infection map; and compare this map with a preexisting S. haematobium map for the region [14] to identify the limitations of targeting PZQ distribution on the basis of urogenital schistosomiasis alone.
H. nana transmission is known to be facilitated by contact with environments contaminated with human faeces, use of inadequate drinking sources, the absence of proper sanitation and ineffective treatment of excreta or waste, deficient personal hygiene, and the presence of another infected person in the household [5, 7, [15] [16] [17] . In line with previous studies, we found that bathing in irrigation canals is an important risk factor for H. nana infection. The irrigation canals are a legacy of the sugar plantation industry set up in the 1950s and surround the provincial capital of Caxito and neighbouring communities. While the sugar mill is no longer in production, the irrigation canals are used by the population for their daily necessities including clothes washing, recreation, and in some instances as a source of drinking water [18] . It has been shown that overcrowded conditions contribute to an increased risk of H. nana infection in children due to a deterioration of the general hygiene situation of the household, which increases faecal-oral transmission of H. nana [4] . Our results indicate that overcrowding is likely to be an important contributor to H. nana infection in that the risk is increased in households with more rooms probably due to the resulting lower hygiene score. This finding is also consistent with the view that hymenolepiasis is more often seen as clusters within a family [2] .The results from our study also demonstrate a possible foodborne source for H. nana infection in that households that reported not washing their vegetables were at increased risk of infection compared to those that do wash their vegetables. This finding is corroborated by a recent study reporting isolation of H. nana eggs from raw vegetables [19] .
While H. nana prevalence in children aged ,5 years was lower compared to children aged $5-15 years, our results suggest an association between H. nana infection and previous history of abdominal pain, and H. nana and T. trichiura coinfections to acute malnutrition in children aged ,5 years. We did not see an independent effect of T. trichiura infection on morbidity. The effect on morbidity identified in this study is consistent with the known pathophysiology of H. nana and T. trichiura worms, which are known to cause inflammation, bleeding, and dysentery through mucosal injury and local, humoral, and cellular responses to infection [4, 20, 21] . The exacerbated morbidity profiles observed in children aged ,5 years compared to older children may be a result of the absence of acquired immunity to helminth infections. In addition, the fact that children ,5 years are at increased risk of morbidity is of concern because dose poles are not available for this age group and PZQ delivery for schistosomiasis is aimed at school-age children rather than pre-school children. The fact that H. nana and T. trichiura coinfections are also associated with previous history of abdominal pain and acute malnutrition is a reasonable argument to advocate the delivery of PZQ to the communities with the aim of reducing helminth-associated morbidity in the study area. While albendazole may be made available to this population due to the high endemicity of STHs (,30%), the high spatial heterogeneity of S. haematobium endemicity in the area means that PZQ will not be made available to all communities on an annual basis [13] . The results of our study show that guiding delivery of PZQ solely on schistosomiasis in integrated programmes that also include albendazole is likely to overlook the important interaction of STH with other parasites such as H. nana, which should be the focus of interventions even in areas of low endemicity.
The prevalence of hymenolepiasis in a community can be a useful indicator of the degree of faecal contamination of an environment and/or the level of hygiene practice. Because WASH coverage in subSaharan Africa shows considerable regional disparities [22] [23] [24] , the disease burden due to H. nana infection is likely to be highly geographically variable. Modern geographical risk prediction methods using model-based geostatistics (MBG) provide an extensive set of spatial modeling tools for assessing the geographical overlap of multiple parasite infections and are being used as control tools for targeting helminth interventions [25] . One approach is overlaying prevalence of infection maps for multiple parasites (i.e., coendemicity mapping). To that regard, our predictive map of H. nana infection showed an area of high H. nana risk (prevalence .8%) associated with more populated areas near and around Caxito and a large cluster predicted to the commune of Mabubas that is unrelated to the endemicity of schistosomiasis (Figure 1 ). The fact that areas likely to receive PZQ annually or biannually (due to high to moderate S. haematobium infection, respectively) do not completely overlap with areas of high H. nana prevalence of infection may pose an import gap in PZQ delivery needs ( Figure 1 ). Furthermore, PZQ may not be sufficiently efficacious to eliminate H. nana infection, as effective treatment sometimes requires prolonged therapy with niclosamide (5-7 days) to eliminate emerging adult worms and to eradicate the infection [3] .
The results highlight the need for WASH improvements to be delivered to communities concomitantly with anthelminth therapy if resources are available. The impact of autoinfection is unlikely to change unless WASH interventions are put in place. More importantly, in this study we show for the first time that H. nana infection is an important contributor to infection-associated morbidity, particularly in children aged ,5 years, and that the delivery of PZQ to control schistosomiasis and hymenolepiasis should take into consideration their coendemicity. If delivery of PZQ is based solely on schistosomiasis endemicity thresholds, areas in need of PZQ to treat H. nana infections will be reached at very low frequencies or not at all. However, it remains to be demonstrated whether targeting of communities for PZQ distribution on the basis of H. nana disease burden is likely to be cost-effective, and further economic analysis needs to be conducted. To improve visibility and enhance advocacy for the control of hymenolepiasis, it may be warranted to include this infection in the list of neglected tropical diseases.
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